National and Kapodistrian University of Athens
Ο ρόλος των ενδοκανναβινοειδών στην αθηροσκλήρωση: πειραματική μελέτη
Abstract
dc:descriptionIntroduction: The newly discovered endocannabinoid system contributes tothe physiological regulation of energy balance, food intake and lipid and glucosemetabolism through both central and peripheral effects. The cannabinoids exerttheir pharmacologic action through the interaction with the specific receptors CB1and CB2, while the presence of another receptor is questionable (CB3). The formerreceptors are primarily distributed to the brain and adipose tissue but they are alsofound in the myocardium, vascular endothelium and sympathetic nerve terminals.Apart from their well-known psycho-active properties, novel data have risenconcerning the role of endocannabinoids in cardiovascular system. Underlyingmechanisms of cardiovascular cannabinoid actions may involve not only activationof cannabinoid receptors on peripheral nerves, but also signalling via receptorslocated in the vascular wall. Previous clinical trials reported that the CB1 receptorblocker, rimonabant, had significant effects on lipid parameters and severalcardiovascular risk factors. The influence of that antagonist on body composition,food consumption and metabolic agents has been recently investigated in rodentmodels and human beings. All data indicate a sustained weight loss and anincreased rate of smoking cessation. In particular central blockade decreases foodintake, while peripheral antagonism decreases abdominal fat, triglycerides, sd-LDL,CRP and insulin resistance. Besides this, CB1 receptor antagonist increasesremarkably HDL and adiponectin. Taken all together, it seems that CB1 receptorantagonist exerts multiple anti-atherogenic effects. Finally it remains unclearwhether receptor signalling via endocannabinoids regulates chronic subclinicalinflammation ongoing during atherosclerosis development. Now it’s essential toinvestigate the underlying mechanisms and the influence of these novelpharmaceutical compounds in the treatment of atherosclerosis.Aim: The aim of this study is to investigate the effects of a multi-factorialintervention of canabinnoid receptor antagonist and exercise program on anatherosclerotic animal model. For this purpose we used an animal model, prone toatherosclerosis, and we examined the pharmaceutical+exercise-induced changes inthe cellular and extracellular components, MMPs and TIMPs within theatherosclerotic plaque. Experimental design: Prospective, randomized, controlled, interventionalstudy.Setting: Center of Experimental Surgery, Foundation of BiomedicalResearch, Academy of Athens.Subjects: Male apoE-/- C57BL/6J knockout mice.Methods: At the age of 8 weeks, all mice were randomly assigned to thefollowing groups: a) Control group of atherosclerosis (Co, N=25), b) Exercisegroup (Ex, N=15), c) Rimonabant group (R, N=15), d) Rimonabant + Exercisegroup (REx, N=15). All groups were fed atherogenic, high-fat, diet for 16 weeksand at the end of the 16th week 10 male of Co group were euthanatized. Theremaining mice received normal, low-fat, diet for additional 6 weeks. During thistime period groups Ex and REx underwent an exercise-running program onmotorized treadmill (6weeks, 5days/week, 60min/session, 15m/min, 50), whilegroups R and Rex received the receptor antagonist SR141716 through oral gavageand the control group remained sedentary. At the end of the study all mice wereeuthanatized and the whole aorta from each mouse was excised and was blocked inparaffin for histological analysis. On the aortic sections we measured the lumenarea, the plaque area and the percentage of the aortic narrowing across the aorticarch. Using histochemical and immunohistochemical methods we calculated thepercentage of the atherosclerotic plaque with positive immunoreaction to ΜΜΡ-2,ΜΜΡ-3, ΜΜΡ-8, ΜΜΡ-9, ΤΙΜΡ-1 and ΤΙΜΡ-2. Finally blood sampling, in fastingstate (8 hours), was performed at the beginning and at the end of the study in orderto evaluate serum levels of glucose, total cholesterol, triglycerides, MMP-2, MMP-3, MMP-9 and TIMP-1.Results: The SR 141716 administration along with exercise program resultedin a considerable regression of atherosclerotic plaque burden, without changingbody weight, lipid parameters and glucose levels. Moreover the amount of collagen,elastin, TIMP-1 and TIMP-2 were significantly increased, while the concentrationsof macrophages, MMP-3, MMP-8 and MMP-9 within the atherosclerotic plaquewere considerably reduced. No marked differences between groups were detected insmooth muscle cells and MMP-2 relative area in the atherosclerotic lesions andarterial wall. Regarding serum levels of the above parameters our programmoderated the atherogenic diet-induced increment in MMP-3 and MMP-9 levels and triggered the elevation of TIMP-1 levels, following the changes at thehistological level.Conclusions: The performance of systemic, long-term SR 141716administration along with exercise program in animal model of atherosclerosisresults in the regression of atherosclerotic lesions and exerts beneficial effects onplaque composition and stability. The modification of MMPs and TIMPs modulatesthe above positive angio-protective effects of both intervention more than each onealone. Therefore, long-term combination of SR 141716 and exercise may be a firstlineintervention contributing to plaque stabilization and cardiovascular eventsprevention.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsimpoulas, Michael
- Κατσιμπούλας, Μιχαήλ
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38033